Sudarshan Pharma Ind Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Consistent revenue growth over the last four quarters indicates strong market demand for products.
Improved profit margins in the latest quarter reflect effective cost management strategies.
Increased investment in R&D suggests a focus on innovation and competitiveness in the manufacturing sector.

NEGATIVES

Rising raw material costs have impacted overall profitability, particularly in the latest quarter.
Inventory levels surged recently, indicating potential supply chain inefficiencies.
Declining operating cash flow suggests challenges in meeting short-term financial obligations.

Field	Mar 23	Sep 23	Mar 24	Sep 24	Mar 25	Sep 25
Revenue	265.84	231.80	231.74	227.78	277.26	314.13
Expenses	258.03	223.40	217.33	212.66	253.90	293.88
Operating Profit	7.81	8.40	14.41	15.12	23.36	20.25
Other Income	0.71	1.94	0.66	1.31	1.27	3.07
Interest	3.26	3.21	5.73	7.64	8.26	11.89
Depreciation	0.47	0.61	0.64	1.34	1.11	1.79
Profit Before Tax	4.79	6.52	8.70	6.28	13.61	9.64
Tax	1.25	1.67	2.10	1.60	3.57	1.81
Net Profit	3.53	4.85	6.60	4.67	10.03	7.83
Eps in Rs	1.47	2.02	0.27	0.19	0.42	0.32